Hers vs bmiMD: Wegovy vs compounded tirzepatide, pricing and access

Quick verdict: Hers vs bmiMD

The primary difference in this Hers vs bmiMD comparison is medication type and pricing model. Hers offers FDA-approved Wegovy® (brand-name semaglutide) from $149/mo with a personalized care team and ongoing dose check-ins, while bmiMD offers compounded tirzepatide as low as $139/mo with multi-month pricing and free shipping. Hers requires an active membership to access medication; bmiMD emphasizes subscription plans and free shipping. This review compares those distinctions so you can decide which fits your priorities.

Medication type and regulatory notes

Hers provides FDA-approved, brand-name Wegovy® and states it does not offer compounded medications. The provider materials note that Wegovy® and Zepbound® are FDA-approved for weight loss, and that Ozempic® is FDA-approved for type 2 diabetes but may be prescribed off-label for weight loss at a clinician’s discretion. bmiMD offers compounded tirzepatide. The bmiMD material includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Those are the core regulatory differences between the two services.

See bmiMD tirzepatide plans

Pricing structure and commitments

Hers lists pricing examples such as Wegovy® pill from $149/mo and injectable options from $199/mo. Hers also indicates that an active Hers Weight Loss Membership is required and that membership and medication are billed separately, with membership details noted in provider material. bmiMD lists tiered pricing for compounded tirzepatide with four billing options: $179 month-to-month, $159/mo for three months, $149/mo for six months, and $139/mo for a 12-month plan, and free shipping on every subscription order. bmiMD notes that the lowest price requires a 12-month commitment and that total prepaid charges should be confirmed.

Care model: clinician access and dose management

Hers highlights a personalized care team with ongoing dose check-ins as part of its offering. bmiMD highlights clinician-reviewed online treatment and 24/7 clinician access and online refills and delivery. Both emphasize clinician involvement and that treatment is available only when a licensed clinician determines it is medically appropriate.

Shipping, fees, and logistics

bmiMD advertises free subscription shipping on every order and online refills and delivery. Hers materials note pricing examples and membership requirements and do not present free shipping claims in the captured content. Both providers state prescriptions are required and that availability may vary by state according to the captured material.

Side-by-side snapshot

How to choose between Hers and bmiMD

Compare your priorities against the captured facts. Hers centers on FDA-approved, brand-name Wegovy®, a personalized care team, and a membership model. bmiMD centers on compounded tirzepatide with multi-month pricing tiers, free subscription shipping, and 24/7 clinician access. Both require a licensed clinician to determine medical appropriateness and note state availability considerations.

Review bmiMD subscription options

Choose Hers vs bmiMD if…

• Choose Hers if you want access to FDA-approved, brand-name Wegovy®, a personalized care team, and are prepared to join an active membership that is billed separately from medication.
• Choose bmiMD if you prioritize lower long-term monthly equivalent pricing for compounded tirzepatide, multi-month subscription savings, and free subscription shipping, while acknowledging compounded medications are not FDA-approved and that the lowest price requires a 12-month commitment.

Hers vs bmiMD decisions hinge on whether brand-name FDA approval or lower multi-month compounded pricing matters more to you. Confirm eligibility, total cost, renewal terms and state availability with each provider before enrolling.